Purpose Adverse drug reactions (ADRs) including medication allergies are not well-described among large national cohorts. This study described the most common documented medication allergies and their reactions among a national cohort of Veterans Affairs (VA) inpatients. Methods We evaluated inpatient admissions in any VA Medical Center from 1 January 2000 to 31 December 2014. Each admission was linked with allergy history preceding or upon admission. Individual drugs were aggregated into drug class category including: penicillins, sulfonamides, angiotensin converting enzyme (ACE) inhibitors, opiates, HMG-CoA reductase inhibitors ("statins") and non-steroidal anti-inflammatory inhibitors (NSAID). Results were reported in aggregate and over time. Results Approximately~10.8 million inpatient admissions occurred from 2000 to 2014. We found the most commonly reported allergy drug classes were penicillins (13%, n = 1 410 080), opiates (9.1%, n = 984 978), ACE inhibitors (5.7%, n = 618 075) sulfonamides (5.1%, n = 558 653), NSAIDs (5.1%, n = 551 216) and statins (3.6%, n = 391 983). Several allergy histories increased over time including opiates (6.2 to 11.2%), ACE inhibitors (1.3 to 10.2%), statins (0.3 to 7.3%) and NSAIDs (3.9 to 6.0%). Rash was the most commonly documented reaction on reports for penicillins (25.5%, n = 371 825), sulfonamides (25.6%, n = 165 954) and NSAIDs (10.3%, n = 65 741). The most common reaction for opiates was nausea/vomiting (17.9%, n = 211 864), cough/coughing for ACE inhibitors (41.0%, n = 270 537) and muscle pain/myalgia for statins (34.1%, n = 186 565). Conclusions We report that penicillins and opiates are the most commonly documented drug allergies among VA inpatients, but other drug classes such as ACE inhibitors, statins and NSAIDs are becoming increasingly common. Clinicians also commonly document non-allergic ADRs in the allergy section such as cough or myalgia.
INTRODUCTION
Adverse drug reactions (ADRs) including medication allergies are a common and burdensome reality in patients' treatment. However, ADRs are difficult to study in large databases because they are often not identified in health claims or other reports.
1,2 Allergy databases may represent an important potential data source for studying ADRs. Thus, we undertook a study to describe the most common documented medication allergies and their reactions among inpatients receiving care in the Veterans Affairs (VA) health care system. We focused on the VA health care system for two reasons. First, the VA is the nation's largest integrated health care delivery system, caring for approximately 9 million Veterans and operating 144 medical centers and 1200 outpatient clinics throughout the US. 3 Second, the VA's comprehensive electronic health record includes detailed information on documented "allergies" to specific medications.
METHODS
We evaluated inpatient admissions in any VA Medical Center from 1 January 2000 to 31 December 2014. Admissions included acute care as well as short-stay observations, domiciliary stays or long-term nursing care stays during the study period. Each unique admission was linked with allergy history preceding or upon admission. Allergy histories correspond to the general allergy section of the electronic medical record and could be documented from a variety of previous health encounters (e.g. previous admission, outpatient clinic or pharmacy visit). Individuals without any allergy records were assumed to have no known drug allergies. For comparison to previous studies, we identified individual drugs and combined them into their respective drug class category. 4, 5 Natural and other synthesized penicillins were combined into one "penicillin-class" category (e.g. penicillin, ampicillin, amoxicillin, methicillin, dicloxacillin, oxacillin, nafcillin, piperacillin, carbenicillin and ticarcillin). Sulfonamides included documented "sulfa" allergies not otherwise specified or specific sulfonamide antibiotic (trimethoprim, sulfacetamide, sulfadiazine, sulfamethoxazole, sulfasalazine and dapsone). Angiotensin converting enzyme (ACE) inhibitors included lisinopril, enalapril, ramipril, quinapril, perindopril, benazepril, fosinopril and captopril. Opiates included codeine, morphine, fentanyl, hydromorphone, oxycodone, methadone and meperidine. HMG-CoA reductase inhibitors ("statins") included simvastatin, atorvastatin, rosuvastatin, pravastatin, fluvastatin and lovastatin. Non-steroidal anti-inflammatory inhibitors (NSAID) included aspirin, ibuprofen, naproxen, indomethacin, ketorolac, diclofenac, sulindac, etodolac, piroxicam and meloxicam. This study was approved by the Providence VA Institutional Review Board and Research and Development Committee.
RESULTS
Overall we identified 2 948 543 patients with 10 858 398 admissions from 2000 to 2014. These admissions were included from 127 VA Medical Centers across 48 states, Washington D.C. and Puerto Rico. Among admissions, 95.2% (n = 10 339 233) were male, with a mean age of 63 (AE14 years). We found the most common allergies were penicillins (13%, n = 1 410 080), opiates (9.1%, n = 984 978), ACE inhibitors (5.7%, n = 618 075) sulfonamides (5.1%, n = 558 653), NSAIDs (5.1%, n = 551 216) and statins (3.6%, n = 391 983). The most common individual drugs included penicillin, codeine, lisinopril, simvastatin, morphine, aspirin and trimethoprim/ sulfamethoxazole (Table 1) . Penicillins and sulfonamides allergies increased ≤1% during the study period ( Figure 1 ). The other allergy histories that increased over time included opiates (6.2 to 11.2%), ACE inhibitors (1.3 to 10.2%), statins (0.3 to 7.3%) and NSAIDs (3.9 to 6.0%).
Missing documentation about reactions was common ranging from 22.5 to 43.3% of reports by drug class (Table 1) . Rash was the most commonly documented reaction on reports for penicillins (25.5%, n = 371 825), sulfonamides (25.6%, n = 165 954) and NSAIDs (10.3%, n = 65 741). The most common reaction for opiates was nausea/ vomiting (17.9%, n = 211 864). Cough/coughing was the most common reaction for ACE inhibitor allergy reports (41.0%, n = 270 537). Statin allergies most commonly stated a muscle pain/myalgia reaction on reports (34.1%, n = 186 565).
DISCUSSION
We report that penicillins and opiates are the most commonly documented drug allergies among inpatients in the VA system, but other drug classes such as ACE inhibitors, statins and NSAIDs are becoming increasingly common. Previous studies have found similar rates of penicillin allergies, and it is commonly reported that 10-15% of admitted patients are allergic to penicillins. [6] [7] [8] [9] A similarly designed study of health care plan members in the Southern California Kaiser Permanente system, which included both inpatients and outpatients, found overall lower allergy prevalence rates (penicillin [ However, they also found ACE inhibitors, NSAIDs and narcotics to be among the most commonly reported allergies. At least one other published study has investigated documented allergy trends over time. 4 This single-center study which evaluated allergy prevalence from 1990 to 2013 reported similar prevalence findings for penicillins (12.8%), ACE inhibitors (2.0%), sulfonamides (7.4%), opiates (6.8%) and NSAIDs (3.5%), as well as demonstrating a similar increase in ACE inhibitor, opiate and statin allergies over time. Few studies have described the type of reactions reported by patients/providers. In a non-allergic drug reactions documented as "allergies" [32%] of allergies, respectively. 10 A large national evaluation of outpatient medical records demonstrated that the presence of an "allergic-like event" (a combined definition of anaphylaxis, urticaria, angioedema and severe skin reactions) to penicillin does increase the likely occurrence of another reaction to cephalosporin or sulfonamide, but serious allergic hypersensitivities are relatively rare overall (<0.001%).
11
In our study, the large number of ACE inhibitor and statin "allergies" and their increase over time were unanticipated. ACE inhibitor and statin allergic hypersensitivities have not previously been described with comparable frequency to opiates and sulfonamide drugs. 12 Documentation is subject to the historian judgment and patient recall; therefore, the term "allergy" could also refer to other serious non-allergic ADRs which were deemed appropriate to document at the time. This is supported by our findings on the most commonly described reactions with each drug (Table 1) .
Clinicians may document non-allergic ADRs in the allergy domain to inform other providers to avoid these medications, such as ACE inhibitor-induced cough or muscle pain from statin therapy. These commonly reported ADRs (e.g. ACE inhibitor cough) raise the possibility that the "allergy" histories of VA patients (and possibly other electronic medical record systems) may contain substantial information on a variety of historical ADRs not just allergic reactions.
Review of allergy domains in electronic medical record systems may prove to be an untapped source for pharmacovigilance and post-marketing surveillance of medications. Future electronic health record (EHR) innovations could explicitly divide these sections into "allergy", "intolerance" and "food" to reduce this technical inaccuracy. A system which allows for greater specificity in documenting drug and food reactions could improve patient safety as clinicians will be able to make better informed decisions for patient management in the presence of such reaction histories. A significant limitation to this approach may be the accuracy of the documented allergy. Inaccuracy in documentation can be two-fold: (i) the history could be inaccurately recorded or (ii) the history even when accurately taken from the patient may not actually be related to any real hypersensitivity. Patients with documented penicillin allergies often do not have physiologic reactions, but among other documented "allergies" the overall likelihood of actual ADRs after rechallenge is not well-described. 13 One study compared documented allergy records versus actual patient interview in an emergency department setting and found significant discordance. 14 In our study, the reactions reported generally reflect the ADR profile of that agent (i.e. cough, angioedema, hyperkalemia for ACE inhibitors; Table 1 ) and even if the allergy documentation is inaccurate, these "allergies" could still be useful as they influence treatment decisions regardless of the accuracy. 8 Therefore, we highlight the opportunity to investigate documented "allergies" with regards to general ADR trends and how they impact drug utilization and health outcomes.
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